Comparison of Risedronate to Alendronate and Calcitonin for Early Reduction of Nonvertebral Fracture Risk: Results From a Managed Care Administrative Claims Database

OBJECTIVES: Recent randomized clinical trials have shown that risedronate reduces the risk of nonvertebral fractures and clinical vertebral fractures within 6 months of initiating treatment. The objective of the current study was to determine whether this early antifracture effect could be demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Watts, Nelson B., Worley, Karen, Solis, Amy, Doyel, Joseph, Sheer, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2004
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438061/
https://www.ncbi.nlm.nih.gov/pubmed/15032563
http://dx.doi.org/10.18553/jmcp.2004.10.2.142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438061/
https://www.ncbi.nlm.nih.gov/pubmed/15032563
http://dx.doi.org/10.18553/jmcp.2004.10.2.142

Ejemplares similares